Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine

Author： Saad Everardo   Machado Marcel   Wajsbrot Dalia   Abramoff Roberto   Hoff Paulo   Tabacof Jacques   Katz Artur   Simon Sergio   Gansl René  

Publisher： Humana Press, Inc

ISSN： 1537-3649

Source： International Journal of Gastrointestinal Cancer, Vol.32, Iss.1, 2002-08, pp. : 35-41

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic Impact of Perioperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer

By Kondo Naru  

Annals of Surgical Oncology, Vol. 17, Iss. 9, 2010-09 ,pp. : 2321-2329

Springer Publishing Company

Access to resources Recommend Favorite

Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation

By Katz Matthew  

Annals of Surgical Oncology, Vol. 17, Iss. 7, 2010-07 ,pp. : 1794-1801

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer

By de Lange S.M.   van Groeningen C.J.   Meijer O.W.M.   Cuesta M.A.   Langendijk J.A.   van Riel J.M.G.H.   Pinedo H.M.   Peters G.J.   Meijer S.   Slotman B.J.   Giaccone G.  

European Journal of Cancer, Vol. 38, Iss. 9, 2002-06 ,pp. : 1212-1217

Elsevier

Access to resources Recommend Favorite

Serum Lactate Dehydrogenase Level is a Prognostic Factor in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy

By Turen Selahattin   Ozyar Enis   Altundag Kadri   Gullu Ibrahim   Atahan Ibtisam L.  

Cancer Investigation, Vol. 25, Iss. 5, 2007-07 ,pp. : 315-321

Informa Healthcare

Access to resources Recommend Favorite

Impact of dihydropyrimidine dehydrogenase and γ-glutamyl hydrolase on the outcomes of patients treated with gemcitabine or S-1 as adjuvant chemotherapy for advanced pancreatic cancer

By                

Experimental and Therapeutic Medicine, Vol. 2, Iss. 6, 2011-01 ,pp. : 1097-1103

Spandidos Publications

Access to resources Recommend Favorite